Your Vitamin D Is "Normal" — And Your Insulin Resistance Is Getting Worse Anyway

Authors

The Peptide Dispatch Editorial Team

Overview

This dispatch covers Your Vitamin D Is "Normal" — And Your Insulin Resistance Is Getting Worse Anyway in the research research category, authored by The Peptide Dispatch Editorial Team. Estimated reading time: 9 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.

Abstract

Your last physical reported 25-hydroxyvitamin D at 32 ng/mL. The lab range said 30-100. The note from your physician said "sufficient." That note is the problem. Because while your D level cleared the bar designed in 2010 to prevent **bone disease** in a sedentary, multi-ethnic, multi-generational population, the bar that matters for **insulin sensitivity, immune regulation, mitochondrial function, and visceral fat metabolism** — the things you actually care about as a high-performing professional in your 40s and 50s — sits much higher. This is the Vitamin D version of the same trap we've documented in testosterone, thyroid, cortisol, and homocysteine: the reference range was built to flag pathology, not to optimize performance. And nowhere is the cost of that mismatch more visible than in metabolic health. ## The Pediatric-Bone Bar That Became the Adult-Metabolic Default The 30 ng/mL "sufficiency" threshold for 25-hydroxyvitamin D (25(OH)D) traces back to the 2011 Institute of Medicine report and an Endocrine Society guideline from the same era. Both committees were primarily trying to answer one question: at what serum level do parathyroid hormone (PTH) and bone turnover markers stabilize in the general population? That is a useful question. It is not the *only* question. PTH suppression starts to plateau in many adults somewhere between 30 and 40 ng/mL. So the committees drew a line at 30, called everything below it "deficient" or "insufficient," and called everything above it "sufficient." The downstream consequence: a 47-year-old executive with a 25(OH)D of 31 ng/mL gets the same green check on his patient portal as one at 65 ng/mL. Both are "normal." Both are filed under "no action." But the research on metabolic outcomes — not bone outcomes — keeps pointing the opposite direction. ## What the Recent Metabolic Data Actually Shows Three lines of evidence are worth knowing. **1. The VITAL post-hoc and ancillary analyses.** The VITAL trial (25,871 adu…

More from the Research Library

• Your Homocysteine Number Is the Cardiovascular and Brain Marker Your Doctor Almost Certainly Did Not Run — research
• Your Thyroid Panel Is One Number — And That's Why You Still Feel Like Garbage — research
• Hot Take: The FDA Just Quietly Moved 12 Peptides — And It is Not What Most Clinics Are Telling You — research
• Your Cells Are Running Out of Fuel — And No Standard Blood Panel Is Checking — research
• The 2026 Cholesterol Guidelines Just Changed Everything — And Your Doctor Still Isn't Testing ApoB — research
• You're Hemorrhaging Growth Hormone Every Night — And Your Sleep Tracker Can't See It — research

All information is presented for Research Use Only (RUO). Not medical advice.